Home
Random
Nearby
Log in
Settings
Donate
About Wikidata
Disclaimers
Search
(Q34323656)
Watch
English
Androgen receptor antagonists in castration-resistant prostate cancer.
scientific article
In more languages
edit
Statements
instance of
scholarly article
1 reference
stated in
Europe PubMed Central
PMCID
3788593
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23337756%20AND%20SRC:MED&resulttype=core&format=json
retrieved
22 February 2020
review article
1 reference
stated in
Europe PubMed Central
title
Androgen receptor antagonists in castration-resistant prostate cancer
(English)
1 reference
stated in
Europe PubMed Central
PMCID
3788593
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23337756%20AND%20SRC:MED&resulttype=core&format=json
retrieved
22 February 2020
main subject
prostate cancer
1 reference
based on heuristic
inferred from title
author
Dana E Rathkopf
series ordinal
1
1 reference
stated in
Europe PubMed Central
PMCID
3788593
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23337756%20AND%20SRC:MED&resulttype=core&format=json
retrieved
22 February 2020
author name string
Howard I Scher
series ordinal
2
1 reference
stated in
Europe PubMed Central
PMCID
3788593
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23337756%20AND%20SRC:MED&resulttype=core&format=json
retrieved
22 February 2020
publication date
1 January 2013
1 reference
stated in
Europe PubMed Central
PMCID
3788593
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23337756%20AND%20SRC:MED&resulttype=core&format=json
retrieved
22 February 2020
published in
The Cancer Journal
1 reference
stated in
Europe PubMed Central
PMCID
3788593
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23337756%20AND%20SRC:MED&resulttype=core&format=json
retrieved
22 February 2020
volume
19
1 reference
stated in
Europe PubMed Central
PMCID
3788593
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23337756%20AND%20SRC:MED&resulttype=core&format=json
retrieved
22 February 2020
page(s)
43-49
1 reference
stated in
Europe PubMed Central
PMCID
3788593
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23337756%20AND%20SRC:MED&resulttype=core&format=json
retrieved
22 February 2020
issue
1
1 reference
stated in
Europe PubMed Central
PMCID
3788593
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23337756%20AND%20SRC:MED&resulttype=core&format=json
retrieved
22 February 2020
cites work
Targeting the androgen receptor
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3788593
retrieved
6 July 2018
Abiraterone and novel antiandrogens: overcoming castration resistance in prostate cancer.
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3788593
retrieved
6 July 2018
Increased survival with enzalutamide in prostate cancer after chemotherapy
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3788593
retrieved
6 July 2018
Distinct transcriptional programs mediated by the ligand-dependent full-length androgen receptor and its splice variants in castration-resistant prostate cancer.
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3788593
retrieved
6 July 2018
Outsmarting androgen receptor: creative approaches for targeting aberrant androgen signaling in advanced prostate cancer
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3788593
retrieved
6 July 2018
The androgen/androgen receptor axis in prostate cancer
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3788593
retrieved
6 July 2018
ARN-509: a novel antiandrogen for prostate cancer treatment
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3788593
retrieved
6 July 2018
Everolimus in postmenopausal hormone-receptor-positive advanced breast cancer
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3788593
retrieved
6 July 2018
Beyond castration-defining future directions in the hormonal treatment of prostate cancer
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3788593
retrieved
6 July 2018
Reduced expression of the androgen receptor by third generation of antisense shows antitumor activity in models of prostate cancer
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3788593
retrieved
6 July 2018
Androgen receptor gene expression in prostate cancer is directly suppressed by the androgen receptor through recruitment of lysine-specific demethylase 1.
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3788593
retrieved
6 July 2018
New hormonal therapies for castration-resistant prostate cancer
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3788593
retrieved
6 July 2018
Androgen receptor and its splice variants in prostate cancer
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3788593
retrieved
6 July 2018
Cell autonomous role of PTEN in regulating castration-resistant prostate cancer growth
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3788593
retrieved
6 July 2018
Abiraterone and increased survival in metastatic prostate cancer
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3788593
retrieved
6 July 2018
SLCO2B1 and SLCO1B3 may determine time to progression for patients receiving androgen deprivation therapy for prostate cancer
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3788593
retrieved
6 July 2018
Reciprocal feedback regulation of PI3K and androgen receptor signaling in PTEN-deficient prostate cancer
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3788593
retrieved
6 July 2018
A snapshot of the expression signature of androgen receptor splicing variants and their distinctive transcriptional activities
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3788593
retrieved
6 July 2018
Small molecule inhibitors targeting the "achilles' heel" of androgen receptor activity
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3788593
retrieved
6 July 2018
Expression of SLCO transport genes in castration-resistant prostate cancer and impact of genetic variation in SLCO1B3 and SLCO2B1 on prostate cancer outcomes
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3788593
retrieved
6 July 2018
Phase I dose-escalation study of the novel antiandrogen BMS-641988 in patients with castration-resistant prostate cancer
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3788593
retrieved
6 July 2018
Prednisone plus cabazitaxel or mitoxantrone for metastatic castration-resistant prostate cancer progressing after docetaxel treatment: a randomised open-label trial
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3788593
retrieved
6 July 2018
Drug safety is a barrier to the discovery and development of new androgen receptor antagonists.
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3788593
retrieved
6 July 2018
Constitutively active androgen receptor splice variants expressed in castration-resistant prostate cancer require full-length androgen receptor
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3788593
retrieved
6 July 2018
Integrative genomic profiling of human prostate cancer
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3788593
retrieved
6 July 2018
Regression of castrate-recurrent prostate cancer by a small-molecule inhibitor of the amino-terminus domain of the androgen receptor
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3788593
retrieved
6 July 2018
Antitumour activity of MDV3100 in castration-resistant prostate cancer: a phase 1-2 study
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3788593
retrieved
6 July 2018
Structure-activity relationship for thiohydantoin androgen receptor antagonists for castration-resistant prostate cancer (CRPC)
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3788593
retrieved
6 July 2018
Pharmacokinetic assessment of the uptake of 16beta-18F-fluoro-5alpha-dihydrotestosterone (FDHT) in prostate tumors as measured by PET.
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3788593
retrieved
6 July 2018
Arachidonic acid activation of intratumoral steroid synthesis during prostate cancer progression to castration resistance
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3788593
retrieved
6 July 2018
Development of a second-generation antiandrogen for treatment of advanced prostate cancer
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3788593
retrieved
6 July 2018
CYP17 inhibition as a hormonal strategy for prostate cancer.
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3788593
retrieved
6 July 2018
Maintenance of intratumoral androgens in metastatic prostate cancer: a mechanism for castration-resistant tumor growth
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3788593
retrieved
6 July 2018
Antiandrogen withdrawal in castrate-refractory prostate cancer: a Southwest Oncology Group trial (SWOG 9426)
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3788593
retrieved
6 July 2018
Design and end points of clinical trials for patients with progressive prostate cancer and castrate levels of testosterone: recommendations of the Prostate Cancer Clinical Trials Working Group
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3788593
retrieved
6 July 2018
Modulation of Androgen Receptor Activation Function 2 by Testosterone and Dihydrotestosterone
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3788593
retrieved
6 July 2018
Biology of progressive, castration-resistant prostate cancer: directed therapies targeting the androgen-receptor signaling axis
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3788593
retrieved
6 July 2018
Docetaxel and estramustine compared with mitoxantrone and prednisone for advanced refractory prostate cancer
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3788593
retrieved
6 July 2018
Docetaxel plus prednisone or mitoxantrone plus prednisone for advanced prostate cancer
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3788593
retrieved
6 July 2018
Molecular determinants of resistance to antiandrogen therapy
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3788593
retrieved
6 July 2018
Novel mutations of androgen receptor: a possible mechanism of bicalutamide withdrawal syndrome.
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3788593
retrieved
6 July 2018
Androgen receptor as a target in androgen-independent prostate cancer
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3788593
retrieved
6 July 2018
Mutation of the androgen-receptor gene in metastatic androgen-independent prostate cancer
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3788593
retrieved
6 July 2018
A controlled trial of leuprolide with and without flutamide in prostatic carcinoma
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3788593
retrieved
6 July 2018
Domains of the Human Androgen Receptor Involved in Steroid Binding, Transcriptional Activation, and Subcellular Localization
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3788593
retrieved
6 July 2018
Combined androgen blockade with bicalutamide for advanced prostate cancer: long-term follow-up of a phase 3, double-blind, randomized study for survival
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3788593
retrieved
11 August 2018
Prognostic model for predicting survival in men with hormone-refractory metastatic prostate cancer.
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3788593
retrieved
11 August 2018
Studies on prostatic cancer: I. The effect of castration, of estrogen and of androgen injection on serum phosphatases in metastatic carcinoma of the prostate. 1941.
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3788593
retrieved
11 August 2018
Switch from antagonist to agonist of the androgen receptor bicalutamide is associated with prostate tumour progression in a new model system
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3788593
retrieved
11 August 2018
Chemotherapy with mitoxantrone plus prednisone or prednisone alone for symptomatic hormone-resistant prostate cancer: a Canadian randomized trial with palliative end points.
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3788593
retrieved
11 August 2018
Prostate-specific antigen decline after casodex withdrawal: evidence for an antiandrogen withdrawal syndrome
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3788593
retrieved
11 August 2018
Clinical states in prostate cancer: toward a dynamic model of disease progression
1 reference
stated in
PubMed
reference URL
https://pubmed.ncbi.nlm.nih.gov/23337756
retrieved
12 December 2020
based on heuristic
inferred from PubMed ID database lookup
Identifiers
DOI
10.1097/PPO.0B013E318282635A
1 reference
stated in
Europe PubMed Central
PMCID
3788593
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23337756%20AND%20SRC:MED&resulttype=core&format=json
retrieved
22 February 2020
PMCID
3788593
1 reference
stated in
Europe PubMed Central
PMCID
3788593
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23337756%20AND%20SRC:MED&resulttype=core&format=json
retrieved
22 February 2020
PubMed ID
23337756
1 reference
stated in
Europe PubMed Central
PMCID
3788593
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23337756%20AND%20SRC:MED&resulttype=core&format=json
retrieved
22 February 2020
Sitelinks
Wikipedia
(0 entries)
edit
Wikibooks
(0 entries)
edit
Wikinews
(0 entries)
edit
Wikiquote
(0 entries)
edit
Wikisource
(0 entries)
edit
Wikiversity
(0 entries)
edit
Wikivoyage
(0 entries)
edit
Wiktionary
(0 entries)
edit
Multilingual sites
(0 entries)
edit